News

Serena Williams recently shared that she started taking the GLP-1 drug Zepbound after having her two children. The tennis ...
A new imaging approach reveals how dual agonist drugs like tirzepatide act on the pancreas and brain to regulate blood sugar and appetite.
A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with overweight or obesity, outperforming liraglutide and placebo. Brain ...
FMP, the University of Oxford, and the University of Birmingham have developed a novel imaging approach to track how popular ...
GLP-1RAs were associated with a reduced risk for neurodegenerative and cerebrovascular diseases in type 2 diabetes and obesity.
The anti-obesity medication semaglutide (Wegovy) 'took things up one big notch, and now tirzepatide [which is still awaiting approval for weight loss] is up a little notch above that,' one expert ...
Millions of Americans who have dropped pounds and boosted their health using popular obesity drugs like Wegovy are facing a ...
A higher proportion of sleep medicine providers vs. patients reported CPAP over tirzepatide as their preferred treatment option for comorbid obesity and obstructive sleep apnea, according to data ...
Eli Lilly's orforglipron could have a few advantages over a pill from Novo Nordisk, including a lack of dietary restrictions ...
Tirzepatide has been shown to be effective in OSA, but evidence related to comorbid insomnia and sleep apnea (COMISA) is lacking.
Viking Therapeutics (VKTX 5.71%) fell a whopping 39.2% from their previous close on Tuesday, Aug. 19. Investors were reacting ...